Uncategorized
VIDEO: Evidence mounts showing advantages of anti-VEGF therapy in proliferative diabetic retinopathy
WAIKOLOA, Hawaii — At Retina 2016, Michael S. Ip, MD, describes mounting evidence -- anecdotal data, secondary outcomes data and study results from the DRCR.net Protocol S study -- that anti-VEGF therapy is advantageous in patients with proliferative diabetic retinopathy.